Pfizer kidney cancer drug meets main trial goal - Reuters

[INCIID News Feed]

NorthJersey.com
<img alt="" height="1" width="1" />
Pfizer kidney cancer drug meets main trial goal
Reuters
NEW YORK Nov 19 (Reuters) - Pfizer Inc (PFE.N) said its experimental drug for the treatment of patients with a certain type of kidney cancer met the main goal of significantly extending survival without disease progression in a late-stage study. ...
Pfizer: Cancer drug does well in late-stage studyBusinessWeek
Pfizer Kidney Cancer Drug Axitinib Meets Primary Goal In Late-stage StudyRTT News
Pfizer&#39;s Phase III Trial in mRCC Turns Up Positive ResultsGenetic Engineering News
Proactive Investors USA & Canada -Trading Markets (press release) -SunHerald.com (press release)
all 44 news articles &raquo;


More...